Sanders-Brown Center on Aging’s New Memory Clinic Expands Research, Improves Patient Care

LEXINGTON, Kentucky. (January 11, 2022) – The world is watching University of Kentucky Sanders-Brown Center on Aging for answers to the mysteries of dementia, and the elderly rely on them to help them chart their course towards a healthy and vigorous lifestyle. After expanding their space along North Broadway in Lexington, UK executives decided it was time for Sanders-Brown’s Home for Clinical Research and Patient Care to reflect their reputation – by building them a new home on UK HealthCare’s Turfland campus.

“As global experts in their field, our researchers at the Sanders-Brown Center on Aging are dedicated to finding solutions to one of our society’s greatest medical challenges,” said UK President Eli Capilouto. “Their research and efforts with those affected by this terrible disease have been recognized around the world for decades. “

The Sanders-Brown Expanded Memory Clinic ensures that the work continues. The research team welcomed the first participant to their new home on December 20, 2021. The new facility provides a fluid and less stressful experience for a fragile population. It is essentially a one-stop-shop for memory care and support.

At 15,000 square feet, the new clinic more than doubles the capacity to serve patients and research volunteers. The increased space and updated technology have many other benefits, including:

  • Several disciplines to support healthy aging: medication management, lifestyle adjustments, fight against sleep disorders, reduce the risk of falls and improve financial management.
  • Co-located services including cognitive testing, gait analysis, retinal analysis, EEG / EMG testing, dedicated social work consultation space and patient education / resource rooms.
  • Separate general and extended waiting areas.
  • New telemedicine space to serve patients and families who have difficulty getting around.
  • Close to other UK HealthCare clinics.
  • Better parking and orientation.
  • Increased capacity to deliver community programs.

“The UK is focused on addressing the health issues of Kentuckians and beyond. This is exactly what the Sanders-Brown research team is doing, ”said Mark F. Newman, MD, UK executive vice president for health affairs. “Because of them, we should be proud of the fact that Bluegrass State is home to many leading researchers and physicians around the world when it comes to aging and brain health. “

Sanders-Brown has been around for almost half a century. During that time, they’ve built an international reputation for cutting-edge research into a disease that kills more people each year than breast and prostate cancer combined. At the same time, they brought understanding of dementia to Kentucky, arming thousands of people with the tools and information they need to age gracefully.

“We are the envy of Alzheimer’s research centers across the country for our leadership in the fight against dementia, including one of the largest groups of research volunteers who have agreed to be tracked throughout their lives and donating their brains upon their death, thus providing valuable longitudinal data that could unravel the mystery of the development of this disease – the first step towards a cure, ”said Linda Van Eldik, Ph. D., Director of Sanders-Brown and Dr E. Vernon Smith and Eloise C. Smith Alzheimer’s Research Endowed Chair.

The Sanders-Brown Memory Clinic is where their research intersects patient care. Executives say this expanded clinical space is truly essential to their mission to advance both research and patient care.

“Our new clinic allows us for the first time to truly integrate clinical care with our many beneficial research programs that can support brain health and the discovery of new ways to prevent Alzheimer’s disease and related disorders. We can also provide more comprehensive care and family support, while giving our patients the access to the cutting edge investigational drugs they deserve as part of their clinical care at UK HealthCare, ”said Greg Jicha, MD, Ph.D., director of clinical trials at Sanders-Brown.

Sanders-Brown has proposed 42 clinical trials in the prevention and treatment of dementia since 2015. The new facility allows for the addition of at least 11 additional clinical trials involving 625 additional participants, and will accelerate the transition from discovery to care to patients. In addition, the new clinic will significantly improve the competitiveness of the UK Alzheimer’s Disease Center, run by Sanders-Brown, to assist in the rapid expansion of federal funding for research in aging.

Ultimately, Van Eldik says Sanders-Brown is more than just a research center.

“Our mission is to help patients and their families here and now, not just those who may suffer from dementia in the future,” she said. “Our outreach programs connect patients and their families with the resources they need to manage the ups and downs of the day that’s life with Alzheimer’s disease.

There are approximately 75,000 Kentuckians aged 65 and over living with Alzheimer’s disease. Nationally, nearly six million Americans are living with the disease, and that number is expected to rise to nearly 14 million by 2050. Executives at Sanders-Brown say that looking at these statistics and facts about the disease Alzheimer’s disease, they are convinced that this project will make a difference for many years to come.

“I especially want to thank the many individuals and groups who gave their time and effort to make the new Sanders-Brown Turfland clinic a reality. I am also particularly grateful for the generous financial support from the office of President Eli Capilouto, Vice President for Research, UK HealthCare, UK College of Medicine, Sanders-Brown Center on Aging Philanthropy Council and the Commonwealth of Kentucky, ”said Van Eldik.

The UK Memory Clinic, currently housed in the Kentucky Institute of Neuroscience (KNI) inside the Kentucky Clinic, will also occupy space in Turfland’s new facility.

“With the opening of the new Sanders-Brown Clinical Research Center in Turfland, it made sense for us to move our clinical care services to this location,” said Larry Goldstein, MD, Ruth Louise Works Endowed Professor and President of UK College of Medicine’s Department of Neurology. “Many of our patients with memory disorders also participate in our research programs and our specialists work in both areas. This decision will simplify access for our patients and improve the efficiency of our providers. “

KNI Medical Director Daniel Lee, MD said that because the UK team have been given referrals from all over the US, the ability to bundle various services for their patients is a huge advantage. of this decision.

“With the additional space at Turfland, this will allow us to provide multidisciplinary services such as social workers and neuropsychologists, in addition to clinical care,” he said. coordinated for them from the moment they set foot in the new Sanders-Brown clinic.

The University of Kentucky initiated its aging program in 1963. With a grant from the Eleanor and John Y. Brown Jr. Foundation in 1972, construction of the current Sanders-Brown Research Building began and, with a additional state funding, a biomedical research program has been implemented. In 1979, under the leadership of the late William Markesbery, MD, Sanders-Brown became a national leader in efforts to improve the quality of life for older adults through research and education. Sanders-Brown’s main areas of interest are normal brain aging, Alzheimer’s disease and associated dementias, as well as the risk factors associated with these diseases.

In 1985, the Sanders-Brown Center on Aging at the University of Kentucky for Alzheimer’s Disease was funded as one of the first 10 Alzheimer’s disease research centers funded by the National Institute on Aging, which is part of the National Institutes of Health, price number P30AG072946. Currently only 31 designated Alzheimer’s disease research centers exist in the United States and only nine – including Sanders-Brown – have been continuously funded since the designation was launched.

Comments are closed.